# OnCo record dan-222 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dan-222/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dan-222" ;
  schema:name "DAN-222"@en ;
  schema:description "DAN-222 is an experimental high-capacity drug conjugate from Dantari, in phase 2 trials for HER2-negative metastatic breast cancer; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/dan-222/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/dantari-launches-with-47m-to-make-better-adcs>, <https://www.biopharmadive.com/news/dantari-launch-cancer-drug-conjugates/638266/>, <https://clinicaltrials.gov/api/v2/studies/NCT05261269>, <https://clinicaltrials.gov/api/v2/studies/NCT01042379>, <https://clinicaltrials.gov/search?intr=DAN-222> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "High-capacity drug conjugate (polymer-based)" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:companies <https://onco.cc/companies/dantari/> ;
  onco:trials <https://onco.cc/trials/nct05261269/>, <https://onco.cc/trials/i-spy-2-2/> .